Things We Do for No Reason™: Avoiding intravenous iodinated contrast material in patients with acute kidney injury or chronic kidney disease
- PMID: 40255127
- DOI: 10.1002/jhm.70063
Things We Do for No Reason™: Avoiding intravenous iodinated contrast material in patients with acute kidney injury or chronic kidney disease
References
REFERENCES
-
- Bartels ED, Brun GC, Gammeltoft A, Gjørup PA. Acute annria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand. 1954;150(4):297‐302. doi:10.1111/j.0954-6820.1954.tb18632.x
-
- Barrett BJ, Katzberg RW, Thomsen HS, et al. Contrast‐induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double‐blind comparison of iodixanol and iopamidol. Invest Radiol. 2006;41(11):815‐821. doi:10.1097/01.rli.0000242807.01818.24
-
- Nguyen SA, Suranyi P, Ravenel JG, et al. Iso‐osmolality versus low‐osmolality iodinated contrast medium at intravenous contrast‐enhanced CT: effect on kidney function. Radiology. 2008;248(1):97‐105. doi:10.1148/radiol.2481071484
-
- Thomsen HS, Morcos SK. Risk of contrast‐medium‐induced nephropathy in high‐risk patients undergoing MDCT—a pooled analysis of two randomized trials. Eur Radiol. 2009;19(4):891‐897. doi:10.1007/s00330-008-1206-4
-
- Davenport MS, Perazella MA, Yee J, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and The National Kidney Foundation. Radiology. 2020;294(3):660‐668. doi:10.1148/radiol.2019192094